/ Published in

Dark transparent header

What you can read next

Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9-14 years: results of the long-term extension of the DoRIS randomised trial.
Risk factors for Herpes simplex virus type 2 and HIV among women at high risk in north-western Tanzania: preparing for an HSV-2 intervention trial. Journal of Acquired Immune Deficiency Syndromes 2007; 46: 631-642.
Rapid acquisition of HPV around the time of sexual debut in adolescent girls in Tanzania.